"Even though it is 68 patients, this Phase 2 recruitment should be significantly faster than Phase 1 given all the sites that will be open to recruiting."
Also oncologists will be keener to put people on the trial, and they can sell it better.
Before it was something like "we are running a trial with a new drug. It's appears to be safe. We have high hopes...".
And now "we are running a trial with a new drug. It appears to be effective and patients on the drug have had no side effects at all etc etc... a complete response blah blah..."
Ann: Imugene doses first patient in HER-Vaxx phase 2 trial, page-5
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
0.002(5.41%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 3.6¢ | 4.0¢ | 3.5¢ | $1.163M | 31.27M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 2275218 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 196677 | 3 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
